1. Olivieri B, Betterie C, Zanoni G. Vaccinations and Autoimmune Diseases. Vaccines. 2021; 9, 815.
2. Guimarães LE, Baker B, Perricone C, Shoenfeld Y. Vaccines, adjuvants and autoimmunity. Pharmacological Research 100. 2015; 190-209
3. Vellozzi C, Iqbal S, Broder K. Guillain-Barre Syndrome, Influenza, and Influenza Vaccination: The Epidemiologic Evidence. Vaccines. 2014; 58: 1149-1155
4. Wachira VK, Peixoto HM, Oliveira MRF. Systematic review of factors associated with the development of Guillain-Barre syndrome 2007-2017: what has changed? Tropical Medicine and International Health. 2019; 24(2): 132-142.
5. Babazadeh A, Afshar ZM, Javanian M, Afrouzi MM, Karkhah A, Roudsari JM, Sabbagh P, Koppolu V, Vasigala VK, Ebrahimpour S. Influenza vaccination and Guillain-Barre syndrome: Reality or fear. Journal of Translational Internal Medicine. 2019; 7(4): 137-142
6. Soni R, Heindl SE, Wiltshire DA, Vahora IS, Khan S. Antigenic Variability a Potential Factor in Assessing Relationship Between Guillain Barre Syndrome and Influenza Vaccine – Up to Date Literature Review. Cureus. 2020; 12(9): e10208
7. Vellozzi C, Iqbal S, Stewart B, Tokars J, DeStefano F. Cumulative Risk of Guillain-Barre Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic. American Journal of Public Health. 2014; 104(4): 696-701
8. Oo WM, Giri P, Souza AD. AstraZeneca COVID-19 vaccine and Guillain-Barre Syndrome in Tasmania: A causal link? Journal of Neuroimmunology. 2021; 360
9. Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine. Cureus. 2021; 13(2): e13426
10. McKean N, Chircop C. Guillain-Barre syndrome after COVID-19 vaccination. BMJ Case Rep. 2021; 14:e244125
11. Park YS, Lee KJ, Kim SW, Kim KM, Suh BC. Clinical Features of Post-Vaccination Guillain-Barre Syndrome (GBS) in Korea. The Korean Academy of Medical Sciences. 2017; 32: 1154-1159
12. Korinthenberg R, Sejvar JJ. The Brighton Collaboration case definition: Comparison retrospective and prospective cohort of children with Guillain-Barre syndrome. J Peripher Nerv Syst. 2020; 25: 344-349
13. Ghazanfar H, Qazi R, Ghazanfar A, Iftekhar S. Significance of Brighton Criteria in the Early Diagnosis and Management of Guillain-Barre Syndrome. Cureus. 2020; 12(5): e8318